I think you misread the poster(which is really easy I did several times too). > In the US, we have a ban on re-importing cheaper drugs which our companies prod

I think you misread the poster(which is really easy I did several times too). > In the US, we have a ban on re-importing cheaper drugs which our companies produce > We do not admit competitive medications from other first world countries without full FDA approval. This second sentence doesn't refer to the first sentence. But a separate practice of requiring full FDA approval for a drug like Tianeptine which has a long history of being an antidepressant in Europe. But to the point that you made I think it's fair to argue that when you have a monopolistic seller having oligopsonistic buyers is probably closer to a competitive market than just a monopolistic seller.